CD59 anticorps (AA 52-100) (Cy3)
Aperçu rapide pour CD59 anticorps (AA 52-100) (Cy3) (ABIN732341)
Antigène
Voir toutes CD59 AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- AA 52-100
-
Réactivité croisée
- Humain
-
Purification
- Purified by Protein A.
-
Immunogène
- KLH conjugated synthetic peptide derived from human CD59
-
Isotype
- IgG
-
-
-
-
Indications d'application
-
FCM 1:20-100
IF(IHC-P) 1:50-200
IF(IHC-F) 1:50-200
IF(ICC) 1:50-200 -
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- 1 μg/μL
-
Buffer
- Aqueous buffered solution containing 0.01M TBS ( pH 7.4) with 1 % BSA, 0.03 % Proclin300 and 50 % Glycerol.
-
Agent conservateur
- ProClin
-
Précaution d'utilisation
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE, which should be handled by trained staff only.
-
Stock
- -20 °C
-
Stockage commentaire
- Store at -20°C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles.
-
Date de péremption
- 12 months
-
-
- CD59
-
Autre désignation
- Cd59
-
Sujet
-
Synonyms: 1F5, EJ16, EJ3, EL32, G344, MIN1, MIN2, MIN3, MIRL, HRF2, MACIF, MEM43, MIC11, MSK21, 16.3A5, HRF-2, MAC-IP, p18-2, CD59 glycoprotein, 1F5 antigen, 2 kDa homologous restriction factor, MAC-inhibitory protein, MEM43 antigen, Membrane attack complex inhibition factor, Membrane inhibitor of reactive lysis, Protectin, CD59
Background: Potent inhibitor of the complement membrane attack complex (MAC) action. Acts by binding to the C8 and/or C9 complements of the assembling MAC, thereby preventing incorporation of the multiple copies of C9 required for complete formation of the osmolytic pore. This inhibitor appears to be species-specific. Involved in signal transduction for T-cell activation complexed to a protein tyrosine kinase. The soluble form from urine retains its specific complement binding activity, but exhibits greatly reduced ability to inhibit MAC assembly on cell membranes.
-
ID gène
- 966
-
UniProt
- P13987
-
Pathways
- Système du Complément
Antigène
-